WCN24-1799 HEMATURIA RESOLUTION WITH THE APRIL-BLOCKING MONOCLONAL ANTIBODY, SIBEPRENLIMAB, IN PATIENTS WITH IgA NEPHROPATHY IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924003474 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849468396816564224 |
|---|---|
| author | Jonathan Barratt Richard Lafayette Hitoshi Suzuki Sreelatha Melamadothil Laura Kooeinga Chula Herath Muh Geot Wong David Oldach Asher Schachter Mohit Mathur Yusuke Suzuki |
| author_facet | Jonathan Barratt Richard Lafayette Hitoshi Suzuki Sreelatha Melamadothil Laura Kooeinga Chula Herath Muh Geot Wong David Oldach Asher Schachter Mohit Mathur Yusuke Suzuki |
| author_sort | Jonathan Barratt |
| collection | DOAJ |
| format | Article |
| id | doaj-art-b3a3d8487f7940399c99bae382eef8c1 |
| institution | Kabale University |
| issn | 2468-0249 |
| language | English |
| publishDate | 2024-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj-art-b3a3d8487f7940399c99bae382eef8c12025-08-20T03:25:53ZengElsevierKidney International Reports2468-02492024-04-0194S125S12610.1016/j.ekir.2024.02.258WCN24-1799 HEMATURIA RESOLUTION WITH THE APRIL-BLOCKING MONOCLONAL ANTIBODY, SIBEPRENLIMAB, IN PATIENTS WITH IgA NEPHROPATHY IN A PHASE 2 RANDOMIZED CONTROLLED TRIALJonathan Barratt0Richard Lafayette1Hitoshi Suzuki2Sreelatha Melamadothil3Laura Kooeinga4Chula Herath5Muh Geot Wong6David Oldach7Asher Schachter8Mohit Mathur9Yusuke Suzuki10Leicestershire, College of Life Sciences, United KingdomDepartment of Medicine, Stanford University, StanfordDepartment of Nephrology, Juntendo University Urayasu Hospital, ChibaDepartment of Nephrology, Government Medical College, Kozhikode, KeralaResearch Division, Colorado Kidney Care, DenverDepartment of Nephrology Unit, Sri Jayewardenepura General Hospital, NugegodaRenal Research, Concord Repatriation General Hospital, ConcordNephrology Clinical Development, Visterra, Inc, BostonNephrology Clinical Development, Visterra, Inc, BostonNephrology Clinical Development, Visterra, Inc, BostonDepartment of Nephrology, Juntendo University Faculty of Medicine, Tokyo,http://www.sciencedirect.com/science/article/pii/S2468024924003474 |
| spellingShingle | Jonathan Barratt Richard Lafayette Hitoshi Suzuki Sreelatha Melamadothil Laura Kooeinga Chula Herath Muh Geot Wong David Oldach Asher Schachter Mohit Mathur Yusuke Suzuki WCN24-1799 HEMATURIA RESOLUTION WITH THE APRIL-BLOCKING MONOCLONAL ANTIBODY, SIBEPRENLIMAB, IN PATIENTS WITH IgA NEPHROPATHY IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL Kidney International Reports |
| title | WCN24-1799 HEMATURIA RESOLUTION WITH THE APRIL-BLOCKING MONOCLONAL ANTIBODY, SIBEPRENLIMAB, IN PATIENTS WITH IgA NEPHROPATHY IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL |
| title_full | WCN24-1799 HEMATURIA RESOLUTION WITH THE APRIL-BLOCKING MONOCLONAL ANTIBODY, SIBEPRENLIMAB, IN PATIENTS WITH IgA NEPHROPATHY IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL |
| title_fullStr | WCN24-1799 HEMATURIA RESOLUTION WITH THE APRIL-BLOCKING MONOCLONAL ANTIBODY, SIBEPRENLIMAB, IN PATIENTS WITH IgA NEPHROPATHY IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL |
| title_full_unstemmed | WCN24-1799 HEMATURIA RESOLUTION WITH THE APRIL-BLOCKING MONOCLONAL ANTIBODY, SIBEPRENLIMAB, IN PATIENTS WITH IgA NEPHROPATHY IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL |
| title_short | WCN24-1799 HEMATURIA RESOLUTION WITH THE APRIL-BLOCKING MONOCLONAL ANTIBODY, SIBEPRENLIMAB, IN PATIENTS WITH IgA NEPHROPATHY IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL |
| title_sort | wcn24 1799 hematuria resolution with the april blocking monoclonal antibody sibeprenlimab in patients with iga nephropathy in a phase 2 randomized controlled trial |
| url | http://www.sciencedirect.com/science/article/pii/S2468024924003474 |
| work_keys_str_mv | AT jonathanbarratt wcn241799hematuriaresolutionwiththeaprilblockingmonoclonalantibodysibeprenlimabinpatientswithiganephropathyinaphase2randomizedcontrolledtrial AT richardlafayette wcn241799hematuriaresolutionwiththeaprilblockingmonoclonalantibodysibeprenlimabinpatientswithiganephropathyinaphase2randomizedcontrolledtrial AT hitoshisuzuki wcn241799hematuriaresolutionwiththeaprilblockingmonoclonalantibodysibeprenlimabinpatientswithiganephropathyinaphase2randomizedcontrolledtrial AT sreelathamelamadothil wcn241799hematuriaresolutionwiththeaprilblockingmonoclonalantibodysibeprenlimabinpatientswithiganephropathyinaphase2randomizedcontrolledtrial AT laurakooeinga wcn241799hematuriaresolutionwiththeaprilblockingmonoclonalantibodysibeprenlimabinpatientswithiganephropathyinaphase2randomizedcontrolledtrial AT chulaherath wcn241799hematuriaresolutionwiththeaprilblockingmonoclonalantibodysibeprenlimabinpatientswithiganephropathyinaphase2randomizedcontrolledtrial AT muhgeotwong wcn241799hematuriaresolutionwiththeaprilblockingmonoclonalantibodysibeprenlimabinpatientswithiganephropathyinaphase2randomizedcontrolledtrial AT davidoldach wcn241799hematuriaresolutionwiththeaprilblockingmonoclonalantibodysibeprenlimabinpatientswithiganephropathyinaphase2randomizedcontrolledtrial AT asherschachter wcn241799hematuriaresolutionwiththeaprilblockingmonoclonalantibodysibeprenlimabinpatientswithiganephropathyinaphase2randomizedcontrolledtrial AT mohitmathur wcn241799hematuriaresolutionwiththeaprilblockingmonoclonalantibodysibeprenlimabinpatientswithiganephropathyinaphase2randomizedcontrolledtrial AT yusukesuzuki wcn241799hematuriaresolutionwiththeaprilblockingmonoclonalantibodysibeprenlimabinpatientswithiganephropathyinaphase2randomizedcontrolledtrial |